Hager, T.; Borchert, S.; Wessolly, M.; Mathilakathu, A.; Mairinger, E.; Kollmeier, J.; Mairinger, T.; Hegedus, B.; Greimelmaier, K.; Wohlschlaeger, J.;
et al. One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-Radiotherapy. Int. J. Mol. Sci. 2023, 24, 6356.
https://doi.org/10.3390/ijms24076356
AMA Style
Hager T, Borchert S, Wessolly M, Mathilakathu A, Mairinger E, Kollmeier J, Mairinger T, Hegedus B, Greimelmaier K, Wohlschlaeger J,
et al. One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-Radiotherapy. International Journal of Molecular Sciences. 2023; 24(7):6356.
https://doi.org/10.3390/ijms24076356
Chicago/Turabian Style
Hager, Thomas, Sabrina Borchert, Michael Wessolly, Alexander Mathilakathu, Elena Mairinger, Jens Kollmeier, Thomas Mairinger, Balazs Hegedus, Kristina Greimelmaier, Jeremias Wohlschlaeger,
and et al. 2023. "One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-Radiotherapy" International Journal of Molecular Sciences 24, no. 7: 6356.
https://doi.org/10.3390/ijms24076356
APA Style
Hager, T., Borchert, S., Wessolly, M., Mathilakathu, A., Mairinger, E., Kollmeier, J., Mairinger, T., Hegedus, B., Greimelmaier, K., Wohlschlaeger, J., Herrmann, K., & Mairinger, F. D.
(2023). One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-Radiotherapy. International Journal of Molecular Sciences, 24(7), 6356.
https://doi.org/10.3390/ijms24076356
